MyFinsight
Home
Blog
About
Restricted cash
$187K
(-6.97%↓ Y/Y)
Property and equipment,
net
$152K
(-54.08%↓ Y/Y)
Right of use asset
(note 3)
$106K
(-78.59%↓ Y/Y)
Prepaid expenses and
other long-term...
$27K
(12.50%↑ Y/Y)
Other accounts
receivable
$162K
(52.83%↑ Y/Y)
Prepaid expenses and
other current assets
$132K
(-77.44%↓ Y/Y)
Cash and cash
equivalents
$22K
(-97.33%↓ Y/Y)
Total long-term
assets
$472K
(-55.09%↓ Y/Y)
Total current assets
$316K
(-79.14%↓ Y/Y)
Total assets
$788K
(-69.29%↓ Y/Y)
Accumulated deficit
-$242,925K
Treasury stock
$116K
(0.00%↑ Y/Y)
Total liabilities and
stockholders' deficit
$788K
(-69.29%↓ Y/Y)
Total stockholders'
deficit
-$11,597K
(-91.46%↓ Y/Y)
Additional
paid-in-capital
$231,428K
(2.20%↑ Y/Y)
Common stock 0.00005
par value...
$16K
Total liabilities
$12,385K
(43.63%↑ Y/Y)
Total current
liabilities
$12,385K
(45.23%↑ Y/Y)
Accounts payable
$7,488K
(24.86%↑ Y/Y)
Employees related
liability
$3,069K
(82.46%↑ Y/Y)
Short-term loans (note 6)
$1,261K
(1148.51%↑ Y/Y)
Accrued expenses
$454K
(23.71%↑ Y/Y)
Operating lease liability
(note 3)
$113K
(-70.34%↓ Y/Y)
Back
Back
Balance Sheet
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
source: myfinsight.com